About
Rose is a Counsel in our London tax team. She advises clients on the corporate tax law aspects of a broad range of complex domestic and international transactions. Her clients operate across many sectors, though Rose has particular expertise in advising those in the life sciences, energy, private capital and real estate sectors.
Rose specialises in complex domestic and international public and private M&A, reorganisations, reconstructions and demergers, IPOs and other equity capital markets work and group tax structuring. She combines this with a contentious tax practice, which includes advising clients on multi-issue transfer pricing disputes, the application of the offshore fund rules and deducibility of expenses.
Rose is known for providing clear, solutions-focussed advice to her clients. With much of her practice being international, she also has experience in navigating international tax issues as well as UK.
Rose’s experience includes advising:
Life sciences
- AstraZeneca on its harmonised listing structure across the LSE, Nasdaq Stockholm and the NYSE
- AstraZeneca on its $1bn+ acquisition of global clinical-stage biopharmaceutical company Gracell Biotechnologies Inc.
- Grünenthal, the Germany-based global leader in pain management and related diseases, on a joint venture collaboration with Japan-based Kyowa Kirin International
Energy
- Octopus Energy on its demerger and first standalone investment round into technology platform Kraken, at a valuation of $8.65bn
- bp on its agreement to sell a 65% stake in Castrol to Stonepeak at an enterprise value of $10bn
- CPP Investments on its take-private of ReNew Energy at an enterprise value of $10.2bn
Private capital
- CVC on its landmark $15bn IPO on Euronext Amsterdam
- CVC on its acquisition of a majority stake in DIF Capital Partners, a leading infrastructure manager with €16bn of assets under management
- Advent on the sale of Zentiva, a leading European generics pharmaceutical company, to GTCR
Real estate
- Leading German private capital institutions on the £925m refinancing of the Kensington Olympia redevelopment, a multi-use asset comprising an exhibition business, offices, hotels, a school, a gym, and other F&B and leisure operations spread across 14 acres.
- CPP Investments on a joint venture with Round Hill Capital, which will seek to acquire a European student accommodation portfolio (initially) at up to €1bn
- Pandox AB on its acquisition of three aparthotels in central London for £230m
Rose Swaffield
100 Bishopsgate
London EC2P 2SR